mardi 5 avril 2022

The F.D.A. Suspends Use of Glaxo Antibody Drug in the U.S.

Manufacturers said lab testing revealed that the authorized dosage of the drug was not sufficiently potent against BA.2.

from NYT > Health https://ift.tt/qVM5PbF
via health&fitness

Aucun commentaire:

Enregistrer un commentaire